EXACT Therapeutics AS Balance Sheet

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	24.35	99.54	46.43	69.39	82.91
Short-Term Investments	-	-	-	-	20.78
Cash & Short-Term Investments	24.35	99.54	46.43	69.39	103.69
Cash Growth	-75.54%	114.38%	-33.09%	-33.08%	-35.08%
Other Receivables	7	6.69	8.64	8.14	7.61
Receivables	7	6.69	8.64	8.14	7.61
Other Current Assets	29.16	26.98	0.83	-	-
Total Current Assets	60.51	133.21	55.9	77.53	111.3
Property, Plant & Equipment	6.89	4.81	5.42	4.97	6.33
Other Long-Term Assets	-	15.19	0	0	-
Total Assets	67.4	153.2	61.32	82.51	117.63
Accounts Payable	7.45	11.66	7.21	9.55	3.18
Accrued Expenses	9.59	7.27	6.17	4.71	6.33
Current Portion of Leases	0.43	0.59	0.55	0.5	0.36
Other Current Liabilities	19.22	18.08	1.56	1.37	0.66
Total Current Liabilities	36.69	37.6	15.49	16.13	10.53
Long-Term Leases	-	0.05	0.65	1.19	1.35
Other Long-Term Liabilities	0	-	0.12	0.08	0
Total Liabilities	36.69	37.65	16.26	17.4	11.89
Common Stock	0.25	0.25	0.13	0.12	0.12
Additional Paid-In Capital	9.67	96.64	29.44	93.52	215.63
Retained Earnings	-	-	-	-40.1	-122.01
Comprehensive Income & Other	20.78	18.65	15.49	11.57	12.01
Shareholders' Equity	30.71	115.55	45.06	65.11	105.74
Total Liabilities & Equity	67.4	153.2	61.32	82.51	117.63
Total Debt	0.43	0.65	1.2	1.69	1.71
Net Cash (Debt)	23.91	98.89	45.23	67.7	101.97
Net Cash Growth	-75.82%	118.61%	-33.19%	-33.61%	-36.14%
Net Cash Per Share	0.38	2.85	1.41	2.26	3.40
Filing Date Shares Outstanding	63.26	63.26	32.08	30	29.99
Total Common Shares Outstanding	63.26	63.26	32.08	30	29.99
Working Capital	23.82	95.61	40.41	61.41	100.76
Book Value Per Share	0.49	1.83	1.40	2.17	3.53
Tangible Book Value	30.71	115.55	45.06	65.11	105.74
Tangible Book Value Per Share	0.49	1.83	1.40	2.17	3.53
Machinery	18.14	12.96	11.28	8.22	8.02

Source: S&P Global Market Intelligence. Standard template. Financial Sources.